Loading company…
Suzhou-based biotechnology company developing anthelmintic drugs for zoonotic and tropical infectious diseases.
Established in 2012 and based in Suzhou, China, TongliBio develops anthelmintic drugs for tropical infectious diseases and zoonosis, with products TL-010, TL-230 and TL-310. The company closed a strategic investment in September 2020. Its founder, Mingxin Qian, previously worked at Bristol-Myers Squibb and Genentech.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in